Edit |   |
---|---|
Antigenic Specificity | CD40, Human (Lucatumumab biosimilar) |
Clone | Lucatumumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FCM, IP, ELISA, Neut, FuncS, IF, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD40 Recombinant Antibody (Lucatumumab). Lucatumumab (CHIR 12.12 or HCD122) is a human monoclonal antibody against CD40 development of which was discontinued by Novartis in 2013 after it was investigated for the treatment of various types of cancer like multiple myeloma and follicular lymphoma. |
Immunogen | n/a |
Other Names | Anti-CD40 Recombinant Antibody, Research Grade Lucatumumab, Anti-Human CD40 Recombinant Antibody(Lucatumumab), CHIR-12, 12, HCD122, Antibody Drug Analogues, Monoclonal Antibody, YR1112, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 903512-50-5 |
Catalog # | YR1112 |
Price | please inquire |
Order / More Info | CD40, Human (Lucatumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |